CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
P / E vs its own history
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. trades at about 1421.8× earnings — above its 10-year norm (10-year range 23.5×–823.8×, median 30.5×).
Shaded band = 10-year range (23.5×–823.8×); dot = today's 1421.8×.
Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | 0.6% | 5.6% | 14.9% | 16.4% | 16.7% | 14.8% | 13.4% | 14.6% | 15.5% | 14.1% |
| Net margin | -3.6% | 0.5% | 11.5% | 12.2% | 11.0% | 12.5% | 9.6% | 10.0% | 6.6% | 9.2% |
| Return on assets | -2.0% | 0.3% | 5.8% | 6.4% | 5.6% | 6.6% | 5.4% | 5.9% | 4.2% | 5.7% |
| Return on equity | -4.6% | 0.6% | 13.2% | 16.3% | 15.4% | 17.2% | 15.4% | 17.2% | 11.8% | 18.4% |
| Debt / equity | — | — | — | — | — | — | — | 1.23× | 1.04× | 1.42× |
| Current ratio | 1.29 | 1.41 | 1.52 | 1.32 | 1.23 | 1.43 | 1.44 | 1.61 | 1.78 | 1.53 |
Computed from company filings · US · as of 2025-12-27. Facts plus Stocktoria's own computed scores — not investment advice.